Glox Therapeutics, involved in the development of precision antibiotic therapies based on naturally occurring bacteriocins, announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).
Highlighting the impact of ctDNA and NGS for advancing cancer diagnostics and personalized treatment
Find out how CLINICAL24 supporter, the IBMS, has been addressing challenges for biomedical scientists through training, education, and advocacy for over 100 years
This collaboration brings new possibilities for consistent, high-purity cfDNA isolation
3D biology solutions are transforming the way we study complex biological systems. By recreating the architecture and functionality of tissues and organs, these 3D models offer more physiologically relevant insights into cell behavior, disease mechanisms, and drug responses.
Sapio Sciences, the science-aware™ lab informatics platform, has entered a co-marketing agreement with Waters Corporation to enhance data integrity, workflow efficiency, and laboratory productivity
